R1 RCM Overview
Latest P/E ratio for R1 RCM: 1811.39 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow1811.39
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
R1 RCM's p/e ratio stands at 1811.39. That is above the Healthcare sector average of 25.9. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
R1 RCM sits higher the Healthcare benchmark (25.9) with a P/E ratio of 1811.39. That is roughly 6894.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 1811.39 is attractive depends on R1 RCM's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how R1 RCM's P/E ratio evolved across reporting periods, while the comparison chart places RCM next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, P/E ratio is commonly used to spot outliers. R1 RCM's reading of 1811.39 (sector avg 25.9) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
